Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Imen Kahouli"'
Autor:
Catherine Tomaro-Duchesneau, Satya Prakash, Alain Labbé, Imen Kahouli, Mitchell L. Jones, Shyamali Saha, Meenakshi Malhotra, Michael Coussa-Charley
Publikováno v:
Pharmaceuticals, Vol 5, Iss 2, Pp 236-248 (2012)
Probiotics possess potential therapeutic and preventative effects for various diseases and metabolic disorders. One important limitation for the oral delivery of probiotics is the harsh conditions of the upper gastrointestinal tract (GIT) which chall
Externí odkaz:
https://doaj.org/article/a470281e364b497a873e7ed2288107e4
Publikováno v:
Cellular and Molecular Life Sciences. 74:3769-3787
The gut microbiota is essential to health and has recently become a target for live bacterial cell biotherapies for various chronic diseases including metabolic syndrome, diabetes, obesity and neurodegenerative disease. Probiotic biotherapies are kno
Publikováno v:
Applied Microbiology and Biotechnology. 101:1999-2019
Probiotics have been shown to have beneficial properties in attenuating the risk of colorectal cancer (CRC) development. However, functional evidence to support such effects for some probiotic bacteria are relatively unknown. Here, we document a sign
Publikováno v:
Current Drug Delivery. 11:146-153
In this study, we examined the in-vivo characteristics of a novel microencapsulated thalidomide formulation in a murine model of experimental Crohn's disease. Crohn's disease was induced with a single intra-colonic injection of 120 mg/kg of bodyweigh
Autor:
Laetitia Rodes, Meenakshi Malhotra, Arghya Paul, Daniel Marinescu, Shyamali Saha, Satya Prakash, Catherine Tomaro-Duchesneau, Imen Kahouli, Wei Shao
Publikováno v:
Journal of Microencapsulation. 31:230-238
This study evaluates alginate-poly-l-lysine-alginate Bifidobacterium longum subsp. infantis ATCC 15697-loaded microcapsules to enrich the human gut microbiota. The cell survival of alginate-poly-l-lysine-alginate microencapsulated B. infantis ATCC 15
Autor:
Imen Kahouli, Arghya Paul, Wei Shao, Michael Coussa-Charley, Catherine Tomaro-Duchesneau, Daniel Marinescu, Satya Prakash, Laetitia Rodes, Afshan Afsar Khan
Publikováno v:
Journal of Microbiology and Biotechnology. 23:518-526
Gut-derived lipopolysaccharides (LPS) are critical to the development and progression of chronic low-grade inflammation and metabolic diseases. In this study, the effects of probiotics Lactobacillus and Bifidobacterium on gut-derived lipopolysacchari
Publikováno v:
Applied microbiology and biotechnology. 101(5)
Probiotics have been shown to have beneficial properties in attenuating the risk of colorectal cancer (CRC) development. However, functional evidence to support such effects for some probiotic bacteria are relatively unknown. Here, we document a sign
Autor:
Satya Prakash, Nadia R H, Moulay A. Alaoui-Jamali, Imen Kahouli, Meenakshi Malhotra, Anis Riahi
Publikováno v:
Drug Designing: Open Access. 5
Colorectal cancer (CRC), the third cause of cancer deaths worldwide, presents a condition with preventable aspects related to diet, lifestyle, and, in particular host gut microflora. Probiotic regimens have been proposed to diminish CRC risk and comp
Publikováno v:
Journal of Cancer Science & Therapy.
Objective: Lactic acid bacteria such as Lactobacillus fermentum, have shown to increase the levels of fecal short chain fatty acids known with its beneficial role in colonic health and were found to produce anti-carcinogenic compounds, suggesting a p
Autor:
Alaoui-Jamali Ma, Meenakshi Malhotra, Laetitia Rodes, Daniel Marinescu, Satya Prakash, Shyamali Saha, Imen Kahouli, Catherine Tomaro-Duchesneau
Publikováno v:
Journal of Bioequivalence & Bioavailability.
The use of probiotics as preventive agents in colorectal cancer is widely reported in the literature. However, the bioactivity of specific bacterial strains is only partially understood. Here, we identified Lactobacillus reuteri strains with anti-pro